AIM logo

AIM ImmunoTech (AIM)

Profile

Full Name

AIM ImmunoTech Inc.

Ticker Symbol

AIM

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 12, 1996

Indexes

Not included

Website

http://aimimmuno.com

Employees

21

Key Details

Price

$0.03(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$170.00K(-15.84% YoY)

Annual EPS

-$0.31(+48.33% YoY)

PE ratio

-

Next earnings date

May 16, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.03
AIM price is $0.03

30-Day Relative Volume

0.31
AIM 30-day relative volume is 0.31

Price Performance

Price Most recent change

0%
AIM {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

-85%
AIM price is down -85% since January 1st

Price 1-year change

-95.08%
AIM price is down -95.08% year-on-year

Price 3-year change

-97.64%
AIM price is down -97.64% over the past 3 years

Price Range

Price All-time high

$10032.00
AIM price is currently -100.00% below its historical high of $10032.00

Price 3-year low

$0.03
AIM price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.06M
AIM market capitalization is $2.06 million

Market cap 3-year change

-96.62%
AIM market capitalization is down -96.62% over the past 3 years

Market cap All-time high

$497.38M
AIM market capitalization is currently -99.59% below its historical high of $497.38 million

Market cap sector rank

6.74%
AIM market capitalization is higher than 6.74% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+36.82%
AIM shares outstanding is up +36.82% year-on-year

Shares Outstanding 3-Year Change

+43.25%
AIM shares outstanding is up +43.25% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.12
AIM beta is 0.12

200-day SMA

$0.24
AIM price is currently -87.42% below its 200-day simple moving average

50-day SMA

$0.12
AIM price is currently -75.88% below its 50-day simple moving average

RSI

18.29
AIM 14-day relative strength index is 18.29

Volume

0.31
AIM 30-day relative volume is 0.31

ATR

$0.03
AIM average true range is $0.03

10-day Historical Volatility

306.94%
AIM 10-day historical volatility is 306.94%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$170.00K
AIM annual revenue is $170.00 thousand

Revenue Analysts estimate

$2.60M
AIM annual revenue is currently -93.46% lower than the consensus analysts' forecast

Revenue 1-year change

-15.84%
AIM annual revenue is down -15.84% year-on-year

Revenue Sector rank

6.61%
AIM annual revenue is higher than 6.61% of companies in Healthcare sector

EPS

EPS

-$0.31
AIM annual earnings per share is -$0.31

EPS Analysts estimate

-$0.37
AIM annual earnings per share is currently -16.22% lower than the consensus analysts' forecast

EPS 1-year change

+48.33%
AIM annual earnings per share is up +48.33% year-on-year

EPS Sector rank

74.32%
AIM annual earnings per share is higher than 74.32% of companies in Healthcare sector

Profit

Gross profit

$139.00K
AIM annual gross profit is $139.00 thousand

Gross margin

81.76%
AIM annual gross profit margin is 81.76%

Operating profit

-$19.77M
AIM annual operating income is -$19.77 million

Operating margin

-11.63K%
AIM annual operating profit margin is -11.63 thousand%

Net income

-$17.32M
AIM annual net profit is -$17.32 million

Net margin

-10.19K%
AIM annual net profit margin is -10.19 thousand%

Expenses

Total expenses

$19.94M
AIM annual total expenses is $19.94 million

Operating expenses

$19.91M
AIM annual total operating expenses is $19.91 million

Cost of goods sold

$31.00K
AIM annual cost of goods sold is $31.00 thousand

Selling, general & administrative expenses

$13.71M
AIM annual SGA is $13.71 million

Depreciation and amortization

$246.00K
AIM annual depreciation & amortization is $246.00 thousand

Interest expense

$585.00K
AIM annual interest expense is $585.00 thousand

Income tax

-
AIM annual income tax value is unknown

EBIT & EBITDA

EBIT

-$16.73M
AIM annual earnings before interest & taxes is -$16.73 million

EBITDA

-$16.49M
AIM annual EBITDA is -$16.49 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$8.61M
AIM annual total assets is $8.61 million

Non current assets

$4.43M
AIM annual long term assets is $4.43 million

Current assets

$4.18M
AIM annual total current assets is $4.18 million

Cash and cash equivalents

$1.70M
AIM annual cash & cash equivalents is $1.70 million

Accounts receivable

-
AIM annual accounts receivable value is unknown

Inventory

-
AIM annual inventory value is unknown

Liabilities

Total liabilities

$9.93M
AIM annual total liabilities is $9.93 million

Long term liabilities

$395.00K
AIM annual total long term liabilities is $395.00 thousand

Current liabilities

$9.54M
AIM annual total current liabilities is $9.54 million

Accounts payable

$6.38M
AIM annual accounts payable is $6.38 million

Debt

Total debt

$2.94M
AIM annual total debt is $2.94 million

Total debt 1-year change

+309.61%
AIM annual total debt is up +309.61% year-on-year

Long term debt

$395.00K
AIM annual long term debt is $395.00 thousand

Short term debt

$2.55M
AIM annual short term debt is $2.55 million

Equity & Capital

Shareholders equity

-$1.32M
AIM annual stockholders equity is -$1.32 million

Book value

-$1.32M
AIM annual book value is -$1.32 million

Retained earnings

-$426.83M
AIM annual retained earnings is -$426.83 million

Working capital

-$5.36M
AIM annual working capital is -$5.36 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$14.89M
AIM annual cash flow from operations is -$14.89 million

Cash from operations 1-year change

+29.99%
AIM annual cash flow from operations is up +29.99% year-on-year

Cash from investing

$4.71M
AIM annual cash flow from investing activities is $4.71 million

Cash from investing 1-year change

+665.62%
AIM annual cash flow from investing activities is up +665.62% year-on-year

Cash from financing

$6.44M
AIM annual cash flow from financing activities is $6.44 million

Cash from financing 1-year change

+1228.66%
AIM annual cash flow from financing activities is up +1228.66% year-on-year

CAPEX

CAPEX

$556.00K
AIM annual capital expenditures is $556.00 thousand

CAPEX 1-year change

-4.96%
AIM annual capital expenditures is down -4.96% year-on-year

Free Cash Flow

Free cash flow

-$15.44M
AIM annual free cash flow is -$15.44 million

Free cash flow 1-year change

+29.32%
AIM annual free cash flow is up +29.32% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

81.76%
AIM annual gross profit margin is 81.76%

Operating margin

-11.63K%
AIM annual operating profit margin is -11.63 thousand%

Net margin

-10.19K%
AIM annual net profit margin is -10.19 thousand%

ROA & ROE

ROA

-123.76%
AIM annual return on assets is -123.76%

ROE

-388.69%
AIM annual return on equity is -388.69%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AIM price to earnings ratio value is unknown

PE ratio Sector rank

-
AIM price to earnings ratio is unknown

PB Ratio

PB ratio

-1.56
AIM price to book ratio is -1.56

PB ratio Sector rank

6.83%
AIM price to book ratio is higher than 6.83% of companies in Healthcare sector

PS Ratio

PS ratio

12.13
AIM price to sales ratio is 12.13

PS ratio Sector rank

82.31%
AIM price to sales ratio is higher than 82.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.30M
AIM enterprise value is $3.30 million

Enterprise value Sector rank

17.75%
AIM enterprise value is higher than 17.75% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.20
AIM EV/EBITDA is -0.20

EV/EBITDA Sector rank

58.12%
AIM EV/EBITDA is higher than 58.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.44
AIM annual current ratio is 0.44

Quick ratio

-
AIM annual quick ratio value is unknown

Leverage

Debt to equity

-1.75
AIM annual debt to equity ratio is -1.75

Interest coverage ratio

-28.61
AIM annual interest coverage ratio is -28.61

Risk & Stability

Piotroski F-Score

3
AIM piotroski f-score is 3

Altman Z-Score

-76.44
AIM altman z-score is -76.44

Analyst ratings

Recent major analysts updates

Dec 10, 24 Ascendiant Capital
Buy
Oct 22, 24 Maxim Group
Buy
Sep 3, 24 Ascendiant Capital
Buy
Oct 10, 19 Maxim Group
Buy

Institutional Ownership

Similar stocks

NDRA logo
ENDRA Life Sciences (NDRA)
CERO logo
CERo Therapeutics Holdings (CERO)
FOXO logo
FOXO Technologies (FOXO)
EYEN logo
Eyenovia (EYEN)
GCTK logo
GlucoTrack (GCTK)
ZVSA logo
ZyVersa Therapeutics (ZVSA)
QLGN logo
Qualigen Therapeutics (QLGN)
VCNX logo
Vaccinex (VCNX)
PTIX logo
Protagenic Therapeutics (PTIX)
  • What is the ticker symbol for AIM ImmunoTech?
  • Does AIM ImmunoTech pay dividends?
  • What sector is AIM ImmunoTech in?
  • What industry is AIM ImmunoTech in?
  • What country is AIM ImmunoTech based in?
  • When did AIM ImmunoTech go public?
  • Is AIM ImmunoTech in the S&P 500?
  • Is AIM ImmunoTech in the NASDAQ 100?
  • Is AIM ImmunoTech in the Dow Jones?
  • When was AIM ImmunoTech's last earnings report?
  • When does AIM ImmunoTech report earnings?
  • Should I buy AIM ImmunoTech stock now?

What is the ticker symbol for AIM ImmunoTech?

The ticker symbol for AIM ImmunoTech is NYSE American:AIM

Does AIM ImmunoTech pay dividends?

No, AIM ImmunoTech does not pay dividends

What sector is AIM ImmunoTech in?

AIM ImmunoTech is in the Healthcare sector

What industry is AIM ImmunoTech in?

AIM ImmunoTech is in the Biotechnology industry

What country is AIM ImmunoTech based in?

AIM ImmunoTech is headquartered in United States

When did AIM ImmunoTech go public?

AIM ImmunoTech's initial public offering (IPO) was on July 12, 1996

Is AIM ImmunoTech in the S&P 500?

No, AIM ImmunoTech is not included in the S&P 500 index

Is AIM ImmunoTech in the NASDAQ 100?

No, AIM ImmunoTech is not included in the NASDAQ 100 index

Is AIM ImmunoTech in the Dow Jones?

No, AIM ImmunoTech is not included in the Dow Jones index

When was AIM ImmunoTech's last earnings report?

AIM ImmunoTech's most recent earnings report was on Apr 1, 2025

When does AIM ImmunoTech report earnings?

The next expected earnings date for AIM ImmunoTech is May 16, 2025

Should I buy AIM ImmunoTech stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page